R. López-Alemany

发表

α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations

Á. Díaz-Ramos, Anna Roig-Borrellas, Ana García-Melero, 2012, Journal of biomedicine & biotechnology.

uPA deficiency exacerbates muscular dystrophy in MDX mice

A. Luttun, P. Carmeliet, M. Dierssen, 2007, The Journal of cell biology.

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

J. Mora, E. de Álava, H. Keun, 2022, Oncogene.

Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts.

R. López-Alemany, Ò. M. Tirado, 2021, Methods in molecular biology.

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

M. Esteller, J. Mora, S. Moran, 2014, Oncotarget.

LOXL2 Promotes Oncogenic Progression in Alveolar Rhabdomyosarcoma Independently of its Catalytic Activity.

P. Giangrande, D. Herrero-Martín, E. de Álava, 2020, Cancer letters.

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.

P. Carmeliet, P. Muñoz-Cánoves, R. López-Alemany, 2002, Blood.

Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding

J. Redondo, Y. Nagamine, P. Muñoz-Cánoves, 2003 .

Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.

J. Redondo, Y. Nagamine, P. Muñoz-Cánoves, 2003, European journal of biochemistry.

Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase

Jordi Félez, R. López-Alemany, M. Jardí, 2003, American journal of hematology.

Purification of the plasmin receptor from human carcinoma cells and comparison to α-enolase

R. López-Alemany, L. Camoin, P. Burtin, 1994 .

Plasmin-mediated Release of the Guidance Molecule F-spondin from the Extracellular Matrix*

E. Soriano, P. Muñoz-Cánoves, R. López-Alemany, 2001, The Journal of Biological Chemistry.

The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy

N. Mulet-Margalef, D. Herrero-Martín, S. Rello-Varona, 2015, Front. Oncol..

Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

N. Mulet-Margalef, S. Rello-Varona, R. López-Alemany, 2018, Scientific Reports.

DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.

M. Esteller, J. Mora, P. Giangrande, 2017, Cancer letters.

"(Not) all (dead) things share the same breath": identification of cell death mechanisms in anticancer therapy.

D. Herrero-Martín, S. Rello-Varona, R. López-Alemany, 2015, Cancer research.

Cell Death Identification in Anticancer Therapy-Response.

D. Herrero-Martín, S. Rello-Varona, R. López-Alemany, 2015, Cancer research.

uPA deficiency exacerbates muscular dystrophy in MDX mice

A. Luttun, P. Carmeliet, M. Dierssen, 2007, The Journal of Cell Biology.

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

J. Mora, P. Giangrande, D. Herrero-Martín, 2018, International Journal of Cancer.

The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).

P. Muñoz-Cánoves, Á. Díaz-Ramos, R. López-Alemany, 2005, Frontiers in bioscience : a journal and virtual library.

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice.

P. Georges, R. López-Alemany, P. Cígler, 2020, Nanoscale.

Identification of an Epitope of α-Enolase (a Candidate Plasminogen Receptor) by Phage Display

P. Muñoz-Cánoves, Jordi Félez, R. López-Alemany, 1997, Thrombosis and Haemostasis.

Binding of plasminogen to corneal fibroblasts and their extracellular matrix. Evidence for a receptor in cell membranes

R. López-Alemany, P. Burtin, J. Faure, 1995 .

Plasmin generation dependent on α-enolase-type plasminogen receptor is required for myogenesis

P. Muñoz-Cánoves, R. López-Alemany, M. Suelves, 2003, Thrombosis and Haemostasis.

Requirement of Plasminogen Binding to Its Cell-Surface Receptor α-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle

Á. Díaz-Ramos, Anna Roig-Borrellas, Ana García-Melero, 2012, PloS one.

regeneration in vivo Plasmin activity is required for myogenesis in vitro and skeletal muscle

R. López-Alemany, M. Suelves, M. Parra, 2013 .

Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

D. Herrero-Martín, S. Rello-Varona, C. Rodríguez-Galindo, 2016, Oncotarget.

Alpha-enolase plasminogen receptor in myogenesis.

P. Muñoz-Cánoves, Á. Díaz-Ramos, R. López-Alemany, 2005, Frontiers in bioscience : a journal and virtual library.

Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.

P. Muñoz-Cánoves, R. López-Alemany, M. Suelves, 2003, Thrombosis and haemostasis.

Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase.

R. López-Alemany, L. Camoin, P. Burtin, 1994, Thrombosis research.

Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors

William H. Thiel, William H Thiel, P. Giangrande, 2023, Molecular therapy. Nucleic acids.